• My account
    • Cart
    • Checkout
0 Items
Gencyst
  • Home
  • Products
    • Pharma Products
      • Oral Liquids
      • Tablets
      • Injectables
      • Antibiotics (Toll Manufactued)
      • Ointements & Gels Preprations
      • Antibiotics Tablets
      • Capsules
    • Biotech Products
      • ELISA Kit
      • Primary Antibodies
        • Monoclonal Antibodies
        • Polyclonal Antibodies
      • Secondary Antibodies
      • Molecular Biology
        • Nucleic Acid Purification
        • qPCR/RT-PCR
        • Cloning System
        • DNA MolecularWeight Standard
        • Comet Assay
      • Cell Culture
  • Jobs
  • Membership
    • Travel Grant for Gencyst Community
    • Publication Fee Fund
    • Community Fund for Research and Innovation
    • Gencyst Community Membership
    • Membership Packages
  • Contact
  • About
  • Clinical Center-GCC
    • Services
      • Bioavalibility & Bioequivalence Study
      • Therapeutic Equivalence Study
      • Pharmacokinetics Study
      • Toxicology Study
      • Biomarker Testing Services
      • Clinical Trials Phase-I
    • About – GCC
    • Our Team-GCC
    • Our Partners-GCC
    • Licenses & Certificates
    • Volunteers
      • Sign up for Research
      • Answers on questions
      • Conditions for volunteers
Select Page

Gencyst biotech is located at Helsinki, Finland, nurturing a fast developing biotech industry in the research field of molecular biology, immunology, nanomedicines, and biomedical services. Gencyst is a high-tech company focusing on manufacture/distribution of advanced products to support research and development (R&D) around the globe in the field of biological sciences.

Account

  • My Account
  • Account Details
  • Account Details
  • Orders History
  • Orders History
  • Cart
  • Checkout
  • Shop

How can we help you?

Customer Service: (+358) 4578311984

Open – Close: 09:00 – 8:00
Mail: info@gencyst.com

Address:
Jannetie 5E 41, 00370 Helsinki, Finland

Payment accept

Designed by Nexro Developers (An Development and Designing Company) | © 2015 - 2022 All Rights Reserved